Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker.

MLA

Núñez, Christian, et al. “Orbitofrontal Cortex Hypergyrification in Hallucinating Schizophrenia Patients: Surface Ratio as a Promising Brain Biomarker.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, vol. 89, Dec. 2024, pp. 47–55. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2024.09.006.

APA

Núñez, C., Stephan-Otto, C., Roldán, A., Grasa, E. M., Escartí, M. J., Aguilar García-Iturrospe, E. J., García-Martí, G., de la Iglesia-Vaya, M., Nacher, J., Portella, M. J., & Corripio, I. (2024). Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 89, 47–55. https://doi.org/10.1016/j.euroneuro.2024.09.006

Chicago

Núñez, Christian, Christian Stephan-Otto, Alexandra Roldán, Eva Mª Grasa, Mª José Escartí, Eduardo J Aguilar García-Iturrospe, Gracián García-Martí, et al. 2024. “Orbitofrontal Cortex Hypergyrification in Hallucinating Schizophrenia Patients: Surface Ratio as a Promising Brain Biomarker.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology 89 (December): 47–55. doi:10.1016/j.euroneuro.2024.09.006.